Boston

Fenway Fitness Upstart Whoop Muscles to $10 Billion After Cash Flood

AI Assisted Icon
Published on March 31, 2026
Fenway Fitness Upstart Whoop Muscles to $10 Billion After Cash FloodSource: Google Street View

Whoop has locked down a $575 million funding round that pegs the Fenway-based fitness-tech company at roughly $10 billion, a big and relatively rare win for Boston’s startup scene. The fresh capital is set to fuel a major hiring push and help the company take its subscription-and-sensor model into a wider slate of international markets, as per The Boston Globe.

Funding and expansion

As reported by The Boston Globe, the round pulled in strategic backers including the Mayo Clinic and a sovereign wealth fund from Qatar, and it also includes athlete investors. The Boston Globe notes that Whoop now counts about 2.5 million members and that bookings more than doubled in 2025 to top $1 billion, figures that helped underpin the $10 billion valuation.

Big hire plans

Whoop said it will add more than 600 roles this year, most of them based at its Kenmore Square headquarters, according to a press release distributed via Business Wire. The company says it is hiring across software, research and design, hardware, product and marketing as it pushes into Europe, Latin America, Asia and the Gulf states.

Local lift, national ambition

Local investors and officials have welcomed the funding as a boost for the region’s tech ecosystem. “Whoop is 'stepping into the breach to strengthen the local community,'” venture investor Michael Greeley told The Boston Globe, a line that underscores how the company is casting itself as both an economic engine and a civic player.

IPO on the horizon

Company leaders have indicated that a public offering is very much in the cards. Founder and CEO Will Ahmed said the firm is contemplating an IPO "in the next two years," according to Bloomberg, and the new funding gives Whoop room to time that move. The added runway is intended to let the company pick its market moment instead of racing to list under pressure.

Competition and risk

Hardware-plus-subscription models still face real headwinds. Big tech firms already bundle health tracking into phones and watches, and building out clinical-grade integrations can be costly. Whoop’s bet is that its membership analytics and research partnerships will support a premium niche long enough for an IPO to make sense at the new valuation, but at this scale execution is the whole ballgame.

Boston-Science, Tech & Medicine